Samyang Biopharm USA Revenue and Competitors
Estimated Revenue & Valuation
- Samyang Biopharm USA's estimated annual revenue is currently $620k per year.
- Samyang Biopharm USA's estimated revenue per employee is $155,000
Employee Data
- Samyang Biopharm USA has 4 Employees.
- Samyang Biopharm USA grew their employee count by -20% last year.
Samyang Biopharm USA's People
| Name | Title | Email/Phone |
|---|
Samyang Biopharm USA Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Samyang Biopharm USA?
Samyang Biopharm USA, Inc. is the established subsidiary of Samyang Biopharmaceuticals Corporation (Korea) specializing in global biologics development in oncology and rare disease. We seek global in-license rights to late preclinical to Phase 1 antibodies, antibody drug conjugates and recombinant proteins for clinical development with a focus on US Phase 1 trials.
keywords:N/A
N/A
Total Funding
4
Number of Employees
$620k
Revenue (est)
-20%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.1M | 4 | -56% | $20.4M |
#2 | $0.3M | 4 | N/A | N/A |
#3 | $0.1M | 4 | 0% | $13.2M |
#4 | $0.3M | 4 | 33% | N/A |
#5 | $1M | 4 | 0% | N/A |